Gastrointestinal Stromal Tumors (GIST)
3 clinical trials · Condition
◉ Watch Gastrointestinal Stromal Tumors (GIST)
| Record | Firm | Date |
|---|---|---|
| A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT05160168) | Theseus Pharmaceuticals | 2022-01-03 |
| (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors (NCT02508532) | Blueprint Medicines Corporation | 2015-08-01 |
| Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor (NCT00633295) | Novartis Pharmaceuticals | 2008-06-01 |
Track Gastrointestinal Stromal Tumors (GIST) automatically
Every clearance here is in the API, with alerts when new ones post.